Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -76.00% is 30% below its 5-year average of -58.43%, around the middle of its 5-year range (-114.91%–-23.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.84% below its 12-month average of -71.81%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -76.00%.
RETURN ON INVESTED CAPITAL (ROIC)
-76.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-71.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-67.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-58.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.84%
CURRENT VS 3Y AVG
-12.45%
CURRENT VS 5Y AVG
-30.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 724 covered companies
CURRENT VS SECTOR MEDIAN
-126.09%
vs the sector median at left
Immunovant, Inc.
Market Cap
$6.63B
Return on Invested Capital (ROIC)
-76.00%
TTM Avg
-71.81%
3Y Avg
-67.59%
5Y Avg
-58.43%
Market Cap
$6.67B
Return on Invested Capital (ROIC)
19.48%
TTM Avg
18.99%
3Y Avg
19.98%
5Y Avg
22.15%
Market Cap
$6.53B
Return on Invested Capital (ROIC)
-4.30%
TTM Avg
9.38%
3Y Avg
-2.79%
5Y Avg
-9.92%
Market Cap
$6.52B
Return on Invested Capital (ROIC)
13.45%
TTM Avg
11.53%
3Y Avg
6.80%
5Y Avg
5.48%
Market Cap
$6.51B
Return on Invested Capital (ROIC)
11.03%
TTM Avg
15.62%
3Y Avg
13.60%
5Y Avg
7.69%
Market Cap
$6.33B
Return on Invested Capital (ROIC)
-63.96%
TTM Avg
-73.62%
3Y Avg
-66.48%
5Y Avg
-67.69%
Market Cap
$7.04B
Return on Invested Capital (ROIC)
2.12%
TTM Avg
16.37%
3Y Avg
14.48%
5Y Avg
9.33%
Market Cap
$5.95B
Return on Invested Capital (ROIC)
3.91%
TTM Avg
0.53%
3Y Avg
0.65%
5Y Avg
2.31%
Market Cap
$5.94B
Return on Invested Capital (ROIC)
-20.26%
TTM Avg
-47.02%
3Y Avg
-56.93%
5Y Avg
-48.62%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | $6.63B | -76.00% | -71.81% | -67.59% | -58.43% |
| Chemed Corporation (CHE)vs › | $6.67B | 19.48% | 18.99% | 19.98% | 22.15% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.53B | -4.30% | 9.38% | -2.79% | -9.92% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.52B | 13.45% | 11.53% | 6.80% | 5.48% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 11.03% | 15.62% | 13.60% | 7.69% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.33B | -63.96% | -73.62% | -66.48% | -67.69% |
| Alkermes plc (ALKS)vs › | $7.04B | 2.12% | 16.37% | 14.48% | 9.33% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 3.91% | 0.53% | 0.65% | 2.31% |
| GRAIL Inc. (GRAL)vs › | $5.94B | -20.26% | -47.02% | -56.93% | -48.62% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.33B | -20.37% | -14.76% | -15.39% | -11.84% |
ROIC
-76.0%
ROE
-73.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -76.00% |
| 2026-03-31 | -62.50% |
| 2025-12-31 | -49.40% |
| 2025-09-30 | -93.73% |
| 2025-06-30 | -77.41% |
| 2025-03-31 | -61.93% |
| 2024-12-31 | -114.91% |
| 2024-09-30 | -78.49% |
| 2024-06-30 | -54.81% |
| 2024-03-31 | -43.72% |
| 2023-12-31 | -37.33% |
| 2023-09-30 | -97.72% |
| 2023-06-30 | -77.99% |
| 2023-03-31 | -57.45% |
| 2022-12-31 | -46.08% |
| 2022-09-30 | -45.03% |
| 2022-06-30 | -38.07% |
| 2022-03-31 | -33.13% |
| 2021-12-31 | -27.17% |
| 2021-09-30 | -23.79% |
| 2021-06-30 | -30.32% |
| 2021-03-31 | -27.38% |
| 2020-12-31 | -23.87% |
| 2020-09-30 | -17.93% |
| 2020-06-30 | -21.62% |
| 2020-03-31 | -32.94% |
| 2019-12-31 | -10.07% |
| 2019-09-30 | -8.00% |
| 2019-06-30 | -12.97% |
| 2019-03-31 | -6014.50% |
